From Research Stage to GMP Production
News and updates
Resources
On-Demand Webinar: Enabling CTA Submission in Record Time
Why Embrace Learning Empowerment in Biopharma? Insights from 3PBIOVIAN’s Talent Development Journey
Why Embrace Diversity, Equity, And Inclusion (DEI) In The CDMO/Biopharma Sector: Insights From 3PBIOVIAN’s Journey
New Expert Insight Articles Available on Cell & Gene
3PBIOVIAN’s in-house Solution preparation team prepares and provides a wide variety of solutions
Viral safety in viral vector applications – what you need to know?
Support functions at Biovian – warehousing, purchasing, and sterile supply management.
How to select a CDMO for a biopharmaceutical project or program.
Viral Vector and gene therapy basics summarized
Adenovirus vector GMP manufacturing in adherent cell cultures and suspension cell cultures.
Beginner’s guide to the production of AAV vectors for gene therapy – Mentored by a CDMO
Viral Vector process development explained – from Upstream to Downstream
4 Areas where a CDMO can help your Viral Vector project